alexa Comparison Of Screening Method And Cohort Design To Estimate Pertussis Vaccine Effectiveness In Denmark, 2000-2014
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

6th Euro-Global Conference on Infectious Diseases
September 07-09, 2017 | Paris, France

Lara Ricotta, J Nielsen, P Valentiner-Branth and K Mølbak
Department of Infectious diseases Epidemiology, Statens Serum Institut, Copenhagen, Denmark
European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden
ScientificTracks Abstracts: J Infect Dis Ther
DOI: 10.4172/2332-0877-C1-032
Abstract
Background: In Denmark, laboratory-confirmed pertussis is notifiable, and national laboratory, vaccination and population registries permit individual data linkage for analysis. Since 1997, acellular pertussis vaccine has been delivered as a primary series (PS) of three doses at 3, 5 and 12 months, with a pre-school booster at age 5. We estimated VE for children receiving PS versus unvaccinated children, and for those receiving booster dose versus not having received the booster, comparing estimates from a screening method and a cohort design (CD). Methods: The Danish civil registration number was used to link individual case laboratory data to vaccination and population registries. We estimated PS VE by birth cohort from 2000 to 2014, and for the booster from 2000 to 2010, using both methods. For the SM, VE was calculated for PS using the proportion of PS-vaccinated versus totally unvaccinated among cases, and in the population to January 2015. For the CD, linked data was used to estimate time at risk among individuals in each birth cohort from birth or arrival in Denmark, until tested positive for pertussis, moved out of country, death or end of study period. VE was estimated as 1 minus the incidence rate ratio (IRR) between incidence rate (IR = cases/time at risk) among PS-vaccinated and IR for totally unvaccinated using Poisson regression. For the booster, VE was estimated for the booster-vaccinated versus no-booster, independent of other vaccines received. Results: From 2000 to 2015, 3621 confirmed cases were reported among 1,024,906 children in all birth cohorts. Using SM, the median VE for PS was 89.1% (range 63.9% to 99.7%). For the CD, median VE was, 77.2% (range 38.2% to 96.2%). For the booster, SM produced a VE median estimate of 94.0% (range 88.7% to 98.2%), compared to 57.2% (range 50.2% to 69.7%) using CD. Conclusions: This study shows that acellular pertussis vaccine is highly effective. However, VE estimates for children who received PS, and for those who received booster, are substantially higher using SM than CD. CD incorporates the dynamics of time-at-risk and produces a more robust VE estimates. Therefore, SM is likely to overestimate VE, and countries using this approach need to be aware of this limitation. When individual data can be collected or linked, we recommend using the cohort design to obtain a more valid VE estimate.
Biography

Lara Ricotta, she had completed her medicine in preventive medicine, Epidemiology, Public Health and Neurology from 2000-2008 and Preventive Medicine Residency Program (PMRP) from 2010-2015 University of Bologna. She had worked with Istituto Superiore di Sanità, Rome, Italy from 2012 to 2014. And from 2015 to present she is working European Centre for Disease Prevention and Control (ECDC) Università di Bologna.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsych[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords